Divi's Laboratories rose 5.40% to Rs 1,384 at 10:35 IST on BSE after net profit rose 51.84% to Rs 219.02 crore on 25.24% increase in total income to Rs 697.18 crore in Q3 December 2013 over Q3 December 2012.
The company announced the result after trading hours on Monday, 3 February 2014.
Meanwhile, the BSE Sensex was down 177.62 points, or 0.88%, to 20,031.64.
On BSE, so far 58,000 shares were traded in the counter, compared with an average volume of 31,723 shares in the past one quarter.
The stock hit a high of Rs 1,390 so far during the day, which is also a record high for the counter. The stock hit a low of Rs 1,350 so far during the day. The stock hit a 52-week low of Rs 905 on 5 August 2013.
The stock had outperformed the market over the past one month till 3 February 2014, rising 5.07% compared with the Sensex's 3.08% fall. The scrip had outperformed the market in past one quarter, rising 32.78% as against Sensex's 4.85% decline.
More From This Section
The large-cap company has an equity capital of Rs 26.55 crore. Face value per share is Rs 2.
Divi's Laboratories' forex loss amounted to Rs 5 crore in Q3 December 2013 compared with a forex gain of Rs 16 crore in Q3 December 2012.
Divi's Laboratories is primarily engaged in manufacturing active pharmaceutical ingredients (APIs) and intermediates.
Powered by Capital Market - Live News